Lorcaserin
Predictors of Lorcaserin-Induced Weight Loss
Novo Nordisk · Phase 4 · Terminated · Enrollment 32
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Arm A | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm B | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Lorcaserin
Novo Nordisk · Phase 4 · Terminated · Enrollment 32
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Arm A | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm B | Obesity or overweight | n/r | n/r | n/r | n/r |